Is Wegovy Effective? What People on Semaglutide Should Know

Semaglutide, the active substance in Wegovy, is a GLP-1 receptor agonist. GLP-1 is a hormone released naturally after eating; by mimicking it, semaglutide acts on appetite-regulating pathways in the brain and slows gastric emptying. Many people report a noticeable reduction in appetite and food noise — the persistent background thoughts about eating — though the degree varies.

What the evidence indicates

Large clinical trials have found that many people using semaglutide for weight management, alongside dietary changes and physical activity, experienced substantial reductions in body weight. Results were not uniform — some participants lost considerably more than others, and a meaningful proportion maintained results over the trial period. Because this is a prescription medicine, suitability and expected benefit are assessed individually by a prescriber, not a general average.

Factors that influence how well it works

• Consistency — taking each weekly dose on schedule without gaps
• Diet quality — prioritising protein and nutrient-dense foods tends to support results
• Physical activity — movement complements the medicine's appetite effects
• Individual variation — age, starting weight, metabolic health, and other medicines can all play a role
• Dose stage — Wegovy is started at a low dose and adjusted by the prescriber over time; many people notice the most change after dose increases

How Wegovy compares to other medicines

Some people search for whether Wegovy is less effective than Mounjaro (tirzepatide). The two medicines work differently — Mounjaro targets both GLP-1 and GIP receptors, while Wegovy targets GLP-1 alone — and direct comparisons between them are not straightforward. If you are curious about the distinction, our page on how effective Mounjaro is covers the tirzepatide side in more detail. Any decision about which medicine is right for you belongs entirely with your prescriber.

For more background on what Wegovy is and how it is used, see our pages on what Wegovy is and on whether Wegovy is considered a good option — both cover the factual context in more depth. It is also worth knowing that Wegovy and Ozempic share the same active substance, semaglutide, though they are licensed for different purposes.

One of the most useful things you can do while taking Wegovy is track your own data consistently — because effectiveness is personal, and the patterns in your own numbers tell you far more than averages ever could.

GLP Trackr's weight and body tracking feature is built specifically for this. You can log your weight, measurements, and daily check-in details (including mood, energy levels, and food noise) so you can see your actual trend over days and weeks rather than fixating on a single weigh-in. The app's insights layer surfaces correlations in your own data — for example, how your sleep or protein intake relates to the scale moving — which can make conversations with your prescriber much more grounded and specific.

The doctor report feature lets you bring a clear, structured summary of your journey to appointments, so your prescriber has the context they need to assess how things are going and whether any adjustments are appropriate. All decisions about your dose or treatment remain with them — GLP Trackr is there to support your tracking, not to replace their clinical judgement.

For a broader look at how GLP-1 medicines work and what shapes the experience, visit our guide on how GLP-1 and GIP receptor agonists work.

If you notice anything that concerns you — whether results feel very different from what you expected, or you experience symptoms that feel unusual — speak with your healthcare professional promptly rather than adjusting anything yourself.

Want to see your Wegovy journey in one clear place? GLP Trackr is free to try for 7 days — download it on the App Store or Google Play and start logging today.